---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-001785"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2026-01-06T23:59:59+00:00"
generated_at: "2026-05-16T11:29:36.170055+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# China Pharma Holdings shareholders approve reverse stock split up to 1:20 at annual meeting

## Summary
- Elected independent directors Gene Michael Bennett, Yingwen Zhang, Baowen Dong (3,500,418+ votes for each).
- Approved reverse stock split up to 1:20 (3,500,256 for, 780 against); Board has discretion on timing.
- Approved Amendment No.3 to the Amended and Restated 2010 Long-Term Incentive Plan (3,500,258 for).

## SEC filing metadata
- accession: 0001213900-26-001785
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2026-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/0001213900-26-001785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390026001785/ea0271960-8k_chinapharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-001785
- JSON: https://secwatch.observer/filing/0001213900-26-001785.json
- Plain text: https://secwatch.observer/filing/0001213900-26-001785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.